Creska™ is the first “Off-The-Shelf” Adipose Derived Allograft of live young human cellular factors and proteins which does not require an individual to undergo liposuction. Creska’s younger cellular factors and proteins make it the perfect complement to be used with PRP applications utilizing FDA Cleared devices where skin and fat naturally exist so that all uses are homologous.
What is Creska™?
Creska™ is derived from vibrational liposuction technology from thoroughly screened donors and its intended use is for topical, subcutaneous injection, and to be used only where skin and fat naturally exist. Creska contains a high concentration of live, pure human derived cellular factors and proteins.
Creska™ is produced in the United States by an FDA registered lab that is also conducting multiple FDA approved clinical trials in the regenerative medicine industry.
General Application Guidelines
Creska™ can be used anywhere where fat or skin naturally exists subcutaneously injected or applied topically.
Creska™ works best in combination with the many established PRP protocols and was created on the premise that adding younger cells and proteins to aging populations in combination with autologous signaling from platelet derived growth factors should enhance regeneration. Creska™ is an affordable Off-The-Shelf product that should be offered to many PRP candidates.
How does Creska™ work?
Creska™ is derived from dermal adipose tissue that is actually classified as skin. Creska is a homologous Adipose Derived Allograft that behaves in the skin as it was naturally intended to perform. The intent is to aid in the repair, or replaced damaged tissue reconstructs and replaces skin tissue while supplementing natural functions. Creska™ is composed of the same cytokines and growth factors-including collagen, elastin, hyaluronic acid, proteins, nano particles, extra cellular communication mechanisms and human derived cellular factors that exist in tissue to help repair defects where they may exist.
Creska™ when combined with PRP or other autologous treatments will work in conjunction with a person’s own cell signaling and Platelet Derived Growth Factors while adding cushioning and support for tissue, energy storage in the form of lipids and structure of the dermis with the addition of younger cellular factors. It can be used for the repair of cosmetic defects in the skin, repair of injured skin due to surface wounds, as well as provide structural components that may assist in the development of skin structure such as filling gaps in the skin structure and hair follicles.